The pathway model was developed to illustrate each step of the patient pathway for the first year and tree diagrams were constructed (supplementary files 3,4)
In addition to acting through the p38 pathway, GLP-1RAs also promote the increase of PKA levels via the cAMP-dependent pathway, which in turn prevents the phosphorylation of epidermal growth factor receptor (EGFR) and activator of transcription 3 (STAT3), resulting in the inactivation of the EGFR-STAT3 signaling pathway in tumor cells and subsequently downregulating several downstream effector genes such as myelocytomatosis oncogene (c-Myc), survivin, cyclin D1, Bcl-xl, and Bcl-2, thereby inducing apoptosis in tumor cells in a dose-dependent manner [70, 73]
Bu kapsamda semaglutid etken maddesini ieren ve Tip 2 diyabet tedavisinde kullanlan Ozempik'in gvenlik verileri incelenecek
Numerous studies are aimed at identifying the underlying pathophysiology of PMS, yet these studies have only generated a few theories, which require further verification for a comprehensive understanding of the condition
GLP-1 side effects (nausea, diarrhea) cause fluid and electrolyte loss
Early Trials and Testing Early trials were critical in evaluating the safety and efficacy of Semaglutide
